The U.S. Food and Drug Administration on Wednesday advised health providers not to cancel surgical procedures involving the use of medical endoscopes.
Hospitals are just beginning to hash out contingency plans as the waiting begins for the U.S. Supreme Court to decide whether to end insurance subsidies in most of the country.
See a list of selected high-spend hospital products and devices, ranked by percentage change. Source: ECRI Institute. Published March 2, 2015, p. 34.
St. Luke's Health System in Idaho won't be forced to give up its recently acquired physician group just yet, a federal appeals court decided Wednesday.
During oral arguments before the U.S. Supreme Court Wednesday in King v. Burwell, Justice Samuel Alito suggested what he deemed a relatively simple fix to the problem of states without their own exchanges losing premium subsidies. But the solution is not as simple as he portrays it.
Dr. Harold Varmus is resigning from the National Cancer Institute, effective March 31, ending an almost five-year tenure as director of one of the most prominent cancer research organizations in the country.
AbbVie will spend about $21 billion to buy fellow drugmaker Pharmacyclics and add another major revenue producer to a portfolio that already includes the world's top-selling drug.
The American Medical Association and 99 other state medical, medical specialty and professional associations are asking CMS acting Administrator Andrew Slavitt to have the agency do a better job developing transition plans for the Oct. 1 conversion to ICD-10 diagnostic and procedural codes.
U.S. healthcare facilities are improving more rapidly on process measures than they are on clinical outcome measures, according to a new CMS report.
Bill Leaver will retire as CEO of UnityPoint Health in January 2016. Kevin Vermeer, the system's chief strategy officer, will become the next top executive.